QIAGEN OmicSoft and Biomedical Knowledge Base
Checkpoint inhibitors in the context of biomarkers, drug targets and pathways
65 views
In this training, you’ll learn how to:
· Investigate the expression of a gene/biomarker/drug target across different treatments and diseases
· Derive a biomarker/gene signature from a specific condition (for example, non-responders of a drug, or a particular disease/disease subtype and others)
· Correlate expression of multiple genes and biomarkers
· Compare different experimental groups (e.g., your own data and/or public data) at both the levels of gene expression and pathways/regulatory networks activity
Related videos
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft
In this 90-minute training, you'll learn how to perform drug treatment,...
QIAGEN OmicSoft and Biomedical Knowledge Base
Indication expansion and drug repurposing using QIAGEN OmicSoft and Ingenuity Pathway Analysis
Research and development for new drugs and disease treatments can be lengthy...
QIAGEN OmicSoft and Biomedical Knowledge Base
Target exploration and cell line selection for drug discovery
Cancer cell line models have been a cornerstone of cancer research for...
QIAGEN OmicSoft and Biomedical Knowledge Base
Study of public data on inflammatory conditions public data for biomarker and drug target...
In this 90-minute training on QIAGEN OmicSoft and Ingenuity Pathway Analysis...